Mycotopia Therapies Management
Management criteria checks 2/4
We currently do not have sufficient information about the CEO.
Key information
Ben Kaplan
Chief executive officer
US$288.6k
Total compensation
| CEO salary percentage | 99.8% |
| CEO tenure | 3.7yrs |
| CEO ownership | 1.7% |
| Management average tenure | no data |
| Board average tenure | no data |
Recent management updates
No updates
Recent updates
CEO Compensation Analysis
| Date | Total Compensation | Salary | Company Earnings |
|---|---|---|---|
| Jun 30 2024 | n/a | n/a | -US$1m |
| Mar 31 2024 | n/a | n/a | -US$1m |
| Dec 31 2023 | US$289k | US$288k | -US$1m |
| Sep 30 2023 | n/a | n/a | -US$1m |
| Jun 30 2023 | n/a | n/a | -US$1m |
| Mar 31 2023 | n/a | n/a | -US$2m |
| Dec 31 2022 | US$436k | US$288k | -US$3m |
Compensation vs Market: Ben's total compensation ($USD288.64K) is below average for companies of similar size in the US market ($USD677.23K).
Compensation vs Earnings: Ben's compensation has been consistent with company performance over the past year.
CEO
Ben Kaplan (53 yo)
3.7yrs
Tenure
US$288,635
Compensation
Mr. Benjamin Kaplan, also known as Ben, serves as Chairman and President of Mycotopia Therapies Inc. since January 2021. He serves as an Independent Director at Stemtech Corporation (formerly known as Glob...